These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

645 related articles for article (PubMed ID: 32796814)

  • 1. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
    Zhang F; Gan R; Zhen Z; Hu X; Li X; Zhou F; Liu Y; Chen C; Xie S; Zhang B; Wu X; Huang Z
    Signal Transduct Target Ther; 2020 Aug; 5(1):156. PubMed ID: 32796814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Not just antibodies: B cells and T cells mediate immunity to COVID-19.
    Cox RJ; Brokstad KA
    Nat Rev Immunol; 2020 Oct; 20(10):581-582. PubMed ID: 32839569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal Analysis of T and B Cell Receptor Repertoire Transcripts Reveal Dynamic Immune Response in COVID-19 Patients.
    Niu X; Li S; Li P; Pan W; Wang Q; Feng Y; Mo X; Yan Q; Ye X; Luo J; Qu L; Weber D; Byrne-Steele ML; Wang Z; Yu F; Li F; Myers RM; Lotze MT; Zhong N; Han J; Chen L
    Front Immunol; 2020; 11():582010. PubMed ID: 33117392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expansion of plasmablasts and loss of memory B cells in peripheral blood from COVID-19 patients with pneumonia.
    De Biasi S; Lo Tartaro D; Meschiari M; Gibellini L; Bellinazzi C; Borella R; Fidanza L; Mattioli M; Paolini A; Gozzi L; Jaacoub D; Faltoni M; Volpi S; Milić J; Sita M; Sarti M; Pucillo C; Girardis M; Guaraldi G; Mussini C; Cossarizza A
    Eur J Immunol; 2020 Sep; 50(9):1283-1294. PubMed ID: 32910469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: A pilot study in a cohort of Covid-19 Spanish patients.
    Iturrieta-Zuazo I; Rita CG; García-Soidán A; de Malet Pintos-Fonseca A; Alonso-Alarcón N; Pariente-Rodríguez R; Tejeda-Velarde A; Serrano-Villar S; Castañer-Alabau JL; Nieto-Gañán I
    Clin Immunol; 2020 Oct; 219():108572. PubMed ID: 32810602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular immune responses to covid-19.
    Sewell HF; Agius RM; Stewart M; Kendrick D
    BMJ; 2020 Jul; 370():m3018. PubMed ID: 32737031
    [No Abstract]   [Full Text] [Related]  

  • 7. SARS-CoV-2 will constantly sweep its tracks: a vaccine containing CpG motifs in 'lasso' for the multi-faced virus.
    Oberemok VV; Laikova KV; Yurchenko KA; Marochkin NA; Fomochkina II; Kubyshkin AV
    Inflamm Res; 2020 Sep; 69(9):801-812. PubMed ID: 32656668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S Protein-Reactive IgG and Memory B Cell Production after Human SARS-CoV-2 Infection Includes Broad Reactivity to the S2 Subunit.
    Nguyen-Contant P; Embong AK; Kanagaiah P; Chaves FA; Yang H; Branche AR; Topham DJ; Sangster MY
    mBio; 2020 Sep; 11(5):. PubMed ID: 32978311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 herd immunity: where are we?
    Fontanet A; Cauchemez S
    Nat Rev Immunol; 2020 Oct; 20(10):583-584. PubMed ID: 32908300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adaptive immunity against SARS-CoV-2].
    Combadière B
    Med Sci (Paris); 2020 Oct; 36(10):908-913. PubMed ID: 32960167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity.
    Rydyznski Moderbacher C; Ramirez SI; Dan JM; Grifoni A; Hastie KM; Weiskopf D; Belanger S; Abbott RK; Kim C; Choi J; Kato Y; Crotty EG; Kim C; Rawlings SA; Mateus J; Tse LPV; Frazier A; Baric R; Peters B; Greenbaum J; Ollmann Saphire E; Smith DM; Sette A; Crotty S
    Cell; 2020 Nov; 183(4):996-1012.e19. PubMed ID: 33010815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single-cell atlas of the peripheral immune response in patients with severe COVID-19.
    Wilk AJ; Rustagi A; Zhao NQ; Roque J; Martínez-Colón GJ; McKechnie JL; Ivison GT; Ranganath T; Vergara R; Hollis T; Simpson LJ; Grant P; Subramanian A; Rogers AJ; Blish CA
    Nat Med; 2020 Jul; 26(7):1070-1076. PubMed ID: 32514174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
    Sekine T; Perez-Potti A; Rivera-Ballesteros O; Strålin K; Gorin JB; Olsson A; Llewellyn-Lacey S; Kamal H; Bogdanovic G; Muschiol S; Wullimann DJ; Kammann T; Emgård J; Parrot T; Folkesson E; ; Rooyackers O; Eriksson LI; Henter JI; Sönnerborg A; Allander T; Albert J; Nielsen M; Klingström J; Gredmark-Russ S; Björkström NK; Sandberg JK; Price DA; Ljunggren HG; Aleman S; Buggert M
    Cell; 2020 Oct; 183(1):158-168.e14. PubMed ID: 32979941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Single Immunization with Nucleoside-Modified mRNA Vaccines Elicits Strong Cellular and Humoral Immune Responses against SARS-CoV-2 in Mice.
    Laczkó D; Hogan MJ; Toulmin SA; Hicks P; Lederer K; Gaudette BT; Castaño D; Amanat F; Muramatsu H; Oguin TH; Ojha A; Zhang L; Mu Z; Parks R; Manzoni TB; Roper B; Strohmeier S; Tombácz I; Arwood L; Nachbagauer R; Karikó K; Greenhouse J; Pessaint L; Porto M; Putman-Taylor T; Strasbaugh A; Campbell TA; Lin PJC; Tam YK; Sempowski GD; Farzan M; Choe H; Saunders KO; Haynes BF; Andersen H; Eisenlohr LC; Weissman D; Krammer F; Bates P; Allman D; Locci M; Pardi N
    Immunity; 2020 Oct; 53(4):724-732.e7. PubMed ID: 32783919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals.
    Ni L; Ye F; Cheng ML; Feng Y; Deng YQ; Zhao H; Wei P; Ge J; Gou M; Li X; Sun L; Cao T; Wang P; Zhou C; Zhang R; Liang P; Guo H; Wang X; Qin CF; Chen F; Dong C
    Immunity; 2020 Jun; 52(6):971-977.e3. PubMed ID: 32413330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2.
    Catanzaro M; Fagiani F; Racchi M; Corsini E; Govoni S; Lanni C
    Signal Transduct Target Ther; 2020 May; 5(1):84. PubMed ID: 32467561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expansion of atypical memory B cells is a prominent feature of COVID-19.
    Oliviero B; Varchetta S; Mele D; Mantovani S; Cerino A; Perotti CG; Ludovisi S; Mondelli MU
    Cell Mol Immunol; 2020 Oct; 17(10):1101-1103. PubMed ID: 32879471
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute SARS-CoV-2 Infection Impairs Dendritic Cell and T Cell Responses.
    Zhou R; To KK; Wong YC; Liu L; Zhou B; Li X; Huang H; Mo Y; Luk TY; Lau TT; Yeung P; Chan WM; Wu AK; Lung KC; Tsang OT; Leung WS; Hung IF; Yuen KY; Chen Z
    Immunity; 2020 Oct; 53(4):864-877.e5. PubMed ID: 32791036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 Infection.
    Wang Y; Duan F; Zhu Z; Yu M; Jia X; Dai H; Wang P; Qiu X; Lu Y; Huang J
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19.
    Chen X; Pan Z; Yue S; Yu F; Zhang J; Yang Y; Li R; Liu B; Yang X; Gao L; Li Z; Lin Y; Huang Q; Xu L; Tang J; Hu L; Zhao J; Liu P; Zhang G; Chen Y; Deng K; Ye L
    Signal Transduct Target Ther; 2020 Sep; 5(1):180. PubMed ID: 32879307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.